Humanigen\'s therapy to reduce cancertreatment side effects highlighted in premier hematology journal

Humanigen's therapy to reduce cancer-treatment side effects highlighted in premier hematology journal

06:11 EDT 17 May 2019 | Proactive Investors

The article entitled 'CAR-T Cell Neurotoxicity: Hope is on the Horizon' was published in 'blood', widely regarded as a premier hematology journal

More From BioPortfolio on "Humanigen's therapy to reduce cancer-treatment side effects highlighted in premier hematology journal"